Berlin \u2014 The global medi\u00adcal tech\u00adno\u00adlogy company Wallaby Medi\u00adcal acqui\u00adred the German market leader for neuro\u00advas\u00adcu\u00adlar products, phenox GmbH, and its sister company femtos GmbH. The tran\u00adsac\u00adtion was comple\u00adted with a purchase price of appro\u00adxi\u00adm\u00adately \u20ac500 million, inclu\u00adding mile\u00adstone payments. Wallaby Medi\u00adcal finan\u00adced the acqui\u00adsi\u00adtion of phenox using proceeds from its previously closed Series D finan\u00adcing round, which was supported by leading health\u00adcare investors.<\/p>\n
Wallaby Medi\u00adcal and phenox have been stra\u00adte\u00adgic part\u00adners since 2019. phenox exclu\u00adsi\u00advely distri\u00adbu\u00adtes Walla\u00adby\u2019s Avenir\u00ae Coil System in the US and Europe and Walla\u00adby\u2019s Espe\u00adrance\u2122 aspi\u00adra\u00adtion cathe\u00adters in the US market. The now comple\u00adted acqui\u00adsi\u00adtion repres\u00adents one of the largest trans\u00adna\u00adtio\u00adnal tran\u00adsac\u00adtions in the medi\u00adcal device indus\u00adtry and is driven by strong growth oppor\u00adtu\u00adni\u00adties in terms of product port\u00adfo\u00adlio and geogra\u00adphic expan\u00adsion. In perspec\u00adtive, the company will become a global leader in provi\u00adding a wide range of neuro\u00advas\u00adcu\u00adlar tech\u00adno\u00adlo\u00adgies and solu\u00adti\u00adons to custo\u00admers and pati\u00adents around the world, inclu\u00adding the U.S., China, Europe, Japan and other inter\u00adna\u00adtio\u00adnal markets.<\/p>\n
Follo\u00adwing the successful closing, Michael Alper, CEO of Wallaby, will now become CEO of the combi\u00adned company. Prof. Dr.-Ing. Hermann Monstadt, foun\u00adder of phenox, will assume the role of Mana\u00adging Direc\u00adtor of phenox. All exis\u00adting phenox brands will be continued.<\/p>\n
About phenox Advi\u00adsor Wallaby Medi\u00adcal: YPOG<\/strong> About Wallaby Medical<\/strong> About YPOG Berlin \u2014 The global medi\u00adcal tech\u00adno\u00adlogy company Wallaby Medi\u00adcal acqui\u00adred the German market leader for neuro\u00advas\u00adcu\u00adlar products, phenox GmbH, and its sister company femtos GmbH. The tran\u00adsac\u00adtion was comple\u00adted with a purchase price of appro\u00adxi\u00adm\u00adately \u20ac500 million, inclu\u00adding mile\u00adstone payments. Wallaby Medi\u00adcal finan\u00adced the acqui\u00adsi\u00adtion of phenox using proceeds from its previously closed Series D [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":39737,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1367,1368,1372],"tags":[],"class_list":["post-39949","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-consultant"],"yoast_head":"\n
\n<\/strong>
\nSince its foun\u00adding in 2005, phenox has estab\u00adlished itself as a global inno\u00adva\u00adtion leader in neuro\u00advas\u00adcu\u00adlar devices for the inter\u00adven\u00adtio\u00adnal treat\u00adment of stroke. The company has a broad product port\u00adfo\u00adlio cove\u00adring ischemic and hemor\u00adrha\u00adgic stroke treat\u00adment, as well as medi\u00adcal access and care. phen\u00adox\u2019s core products include the p64\/p48 series flow diver\u00adters for the treat\u00adment of intra\u00adcra\u00adnial aneu\u00adrysms and the pRESET series stent retrie\u00advers for mecha\u00adni\u00adcal throm\u00adbec\u00adtomy in ischemic stroke. In addi\u00adtion, phenox has its own coating tech\u00adno\u00adlo\u00adgies to opti\u00admize its perma\u00adnent and short-term implants. Based on inter\u00adna\u00adtio\u00adnally leading clini\u00adcal data, phenox products are distri\u00adbu\u00adted in over 45 count\u00adries world\u00adwide. phenox has subsi\u00addia\u00adries in Italy, Great Britain, Ireland and the USA. https:\/\/phenox.net\/international.<\/p>\n
\nDr. Tim Schl\u00f6s\u00adser (Lead, Corporate\/Transactions), Partner
\nDr. Malte Berg\u00admann (Tax\/Transactions), Partner
\nDr. Stephan Bank (Corporate\/Transactions), Partner
\nDr. J\u00f6rn W\u00f6bke (Corporate\/Transactions), Partner
\nDr. Johan\u00adnes Janning (Corporate\/Transactions), Asso\u00adcia\u00adted Partner
\nDr. Bene\u00addikt Fl\u00f6ter (IP\/IT), Asso\u00adcia\u00adted Partner
\nMatthias Kres\u00adser (Corporate\/Transactions), Asso\u00adcia\u00adted Partner
\nAnn-Kris\u00adtin Loch\u00admann (Tax\/Transactions), Asso\u00adcia\u00adted Partner
\nBarbara Hasse (Corporate\/Transactions), Associate
\nChris\u00adtiane Schnitz\u00adler (Tran\u00adsac\u00adtions), Associate<\/p>\n
\nWallaby Medi\u00adcal is a global medi\u00adcal device company specia\u00adli\u00adzing in the deve\u00adlo\u00adp\u00adment and commer\u00adcia\u00adliza\u00adtion of neuro\u00advas\u00adcu\u00adlar inter\u00adven\u00adtio\u00adnal products for the treat\u00adment of stroke. Walla\u00adby\u2019s product port\u00adfo\u00adlio includes the Avenir\u00ae Coil System, a tech\u00adni\u00adcally diffe\u00adren\u00adtia\u00adted neuro\u00adem\u00adbo\u00adlic coil system for the treat\u00adment of intra\u00adcra\u00adnial aneu\u00adrysms and other neuro\u00advas\u00adcu\u00adlar anoma\u00adlies, the Espe\u00adrance\u2122 Aspi\u00adra\u00adtion Cathe\u00adter, appro\u00adved in the U.S. and China for the treat\u00adment of ischemic stroke, and the Espe\u00adrance\u2122 Distal Access Cathe\u00adter, appro\u00adved in China for deli\u00advery assis\u00adtance. In addi\u00adtion, Wallaby has a full range of neuro\u00advas\u00adcu\u00adlar products in deve\u00adlo\u00adp\u00adment. Walla\u00adby\u2019s products are curr\u00adently distri\u00adbu\u00adted in over 30 count\u00adries and regi\u00adons. For more infor\u00adma\u00adtion, visit www.wallabymedical.com.<\/p>\n
\n<\/strong>
\nYPOG is a specia\u00adlist tax and commer\u00adcial law firm opera\u00adting in the core areas of Corpo\u00adrate, Funds, Liti\u00adga\u00adtion, Tax, Tran\u00adsac\u00adtions, IP\/IT, Notary Services, Banking + Finan\u00adcial Services and FinTech + Block\u00adchain. The YPOG team advi\u00adses a wide variety of clients. These include emer\u00adging tech\u00adno\u00adlogy compa\u00adnies and family-run medium-sized enter\u00adpri\u00adses as well as corpo\u00adra\u00adti\u00adons and private equity\/venture capi\u00adtal funds. YPOG is one of the leading addres\u00adses for venture capi\u00adtal, private equity and fund struc\u00adtu\u00adring in Germany. The firm and its part\u00adners are natio\u00adnally and inter\u00adna\u00adtio\u00adnally ranked by JUVE, Best Lawy\u00aders, Legal 500, Focus, and Cham\u00adbers and Part\u00adners. Today, YPOG employs more than 90 expe\u00adri\u00aden\u00adced lawy\u00aders, tax advi\u00adsors, tax specia\u00adlists and a notary in three offices in Berlin, Hamburg and Colo\u00adgne. www.ypog.law as well as www.linkedin.com\/company\/ypog.<\/p>\n","protected":false},"excerpt":{"rendered":"